Tracheal tubes and airway products sales will strengthen through 2036, anchored by products at 65% of the product type segment in 2026, driven by increasing clinical adoption and expanding procedural volume across hospital systems. The market was valued at USD 2.50 billion in 2025 and is expected to be worth USD 4.46 billion by 2036.